Karl Bozicevic

Bozicevic, Field & Francis, LLP

Involved with developing strategic patent portfolios—IP assets that increase valuations. Works closely with senior management and inventors to capture and exploit the full value and breadth of a company’s innovations. Clients are innovative biotech firms and major universities and research institutions.

Representing award-winning start-up innovators and publicly traded companies. Developed patent portfolios covering transgenic animals and prion assay methodology to form a company based on Nobel Prize winning inventions (www.prionpatents.com), as well as a patent portfolio covering the fluid flow and small particle formation methodology for an award-winning Spanish physicist, which lead to his opportunity to meet with the King of Spain (www.drugdeliverypatents.com). He also led the strategic development of a portfolio of patents protecting an FDA-approved protein therapeutic product critically important to treat patients at risk of completely losing their eyesight, worth billions of dollars in annual sales and withstood challenge by a generic.

I’ve been fortunate to have the opportunity to build IP assets that make a meaningful difference in supporting critically important advancements in medical care to people all over the world.

Karl studied under Professor Irving Kayton, an iconic figure in patent law, while earning his LL.M. from George Washington University.

Irving Kayton was a larger-than-life figure in the world of patent law—exceptionally bright and with imaginative ideas he brought to teaching patent law.  He taught me that being a maverick requires different thinking.